Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The use of cryoablation for B3 fibroepithelial lesions (FELs) of the breast has not been well-documented. Cryoablation offers several advantages over surgery in treating breast masses, including avoidance of general anesthesia, less invasiveness, shorter recovery, and greater cost-effectiveness. This prospective study reported the outcome of a patient with a breast B3 FEL treated with cryoablation. Post-procedure, the patient reported low pain scores, early return to work, and good cosmesis without complications. The mass also reduced in size, demonstrating that cryoablation could be a feasible method to treat such masses. Larger studies with longer-term follow-up are required to validate these findings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jcu.24044 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Limb salvage surgery with cryotherapy in osteosarcoma of the femoral shaft: A case report.
Int J Surg Case Rep
August 2025
Department of Anatomical Pathology, Faculty of Medicine, University of Sumatera Utara, Adam Malik General Hospital, Indonesia.
Introduction And Importance: Osteosarcoma is the most common primary malignant bone tumor, primarily affecting children and adolescents. Treatment is often challenging due to availability of modalities across hospitals. This study reports a case of osteosarcoma located in the midshaft of the femur.
View Article and Find Full Text PDFEfficacy and safety of the CT-guided co-ablation system in the treatment of malignant melanoma with hepatic metastasis.
J Cancer Res Ther
September 2025
Department of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou Guangdong, China.
Purpose: To evaluate the efficacy and safety of computed tomography (CT)-guided co-ablation in patients with hepatic metastases from malignant melanoma.
Methods: Clinical data of 79 patients with hepatic metastases from malignant melanoma who underwent co-ablation (integration of cryoablation and thermal ablation) and programmed death 1 (PD-1) treatment between October 2019 and January 2024 were retrospectively analyzed. The patients were divided into group A (n = 50), patients who received co-ablation, and group B (n = 29), patients who received PD-1 treatment.
Safety and Diagnostic Yield of Transbronchial Cryobiopsy by Flexible Bronchoscopy Under Conscious Sedation Without Intubation in Diffuse Parenchymal Lung Disease.
J Bronchology Interv Pulmonol
October 2025
Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, P.R. China.
Background: Transbronchial cryobiopsy (TBCB) is generally recommended under intubation or rigid bronchoscopy with general anesthesia. However, some patients with diffuse parenchymal lung disease (DPLD) are unable to tolerate general anesthesia, which limits the widespread adoption of TBCB.
Methods: A total of 37 patients with DPLD who underwent TBCB under conscious sedation without intubation were included in this study.
Same Day Discharge Following Minimally Invasive Repair of Pectus Excavatum.
J Pediatr Surg
September 2025
Department of Pediatric Surgery, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, United States.
Introduction: Pectus excavatum is surgically managed with minimally invasive bar placement. Pain control effectively determines the postoperative length of stay (LOS). Pain management after this operation has been transformed with the use of intercostal cryoablation, with LOS of one night being a previous standard of care.
View Article and Find Full Text PDFComparative efficacy and safety of POLARx versus Arctic front advance pro cryoballoon systems for pulmonary vein isolation in atrial fibrillation: an updated systematic review and meta-analysis.
Front Cardiovasc Med
August 2025
Department of Cardiology, MedStar Heart and Vascular Institute, Washington, DC, United States.
Background: Cryoballoon (CB) ablation is a well-established treatment for atrial fibrillation (AF). The Arctic Front Advance Pro™ (AFA-Pro) system, in use for over a decade, has demonstrated consistent efficacy and safety. Recently, the POLARx™, a novel CB system, has gained attention due to its advanced design and comparable clinical outcomes.
View Article and Find Full Text PDF